Fortress Biotech
FBIO
#9355
Rank
โ‚น8.14 B
Marketcap
โ‚น262.29
Share price
1.04%
Change (1 day)
37.68%
Change (1 year)

Revenue for Fortress Biotech (FBIO)

Revenue in 2025 (TTM): โ‚น5.05 Billion

According to Fortress Biotech 's latest financial reports the company's current revenue (TTM ) is โ‚น5.32 Billion. In 2024 the company made a revenue of โ‚น4.94 Billion a decrease over the revenue in the year 2023 that were of โ‚น7.03 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fortress Biotech from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น5.05 B2.13%
2024 โ‚น4.94 B-29.68%
2023 โ‚น7.03 B12.25%
2022 โ‚น6.26 B22.41%
2021 โ‚น5.12 B53.54%
2020 โ‚น3.33 B27.67%
2019 โ‚น2.61 B-127.03%
2018 -โ‚น9.67 Billion-180.67%
2017 โ‚น11.97 B969.51%
2016 โ‚น1.11 B1852.72%
2015 โ‚น57.35 M
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Advaxis
ADXS
โ‚น10.23 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚น44.47 B 734.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น17.32 B 225.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
โ‚น29.68 B 457.35%๐Ÿ‡บ๐Ÿ‡ธ USA